Is REGN or ZTS cheaper?

On trailing earnings, ZTS is cheaper: REGN trades at a 14.92 P/E and ZTS at 13.20.

Which has grown faster, REGN or ZTS?

Over the past five years, REGN grew revenue faster — REGN at a 10.16% CAGR versus ZTS at 6.28%.

Does REGN or ZTS pay a bigger dividend?

REGN yields 0.59% and ZTS yields 2.59% based on trailing dividends and the latest price.

Is REGN or ZTS more profitable?

REGN runs the higher net margin — REGN at 29.65% versus ZTS at 27.79%.

Which has been the better investment, REGN or ZTS?

Over the past 10-year, ZTS delivered the higher annualized total return — REGN at 5.19% versus ZTS at 6.19%. Past performance doesn't predict future results.

Regeneron Pharmaceuticals, Inc. (REGN) vs Zoetis Inc. (ZTS)

ZTS leads on 10 of 16 compared metrics.

A side-by-side comparison of Regeneron Pharmaceuticals, Inc. and Zoetis Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

REGN

Regeneron Pharmaceuticals, Inc.

Total return — REGN vs ZTS

growth of $100 · last 13y

REGN +254.1%ZTS +156.6%REGN compounded faster

REGN ZTS

REGN vs ZTS: by the numbers

•REGN is the larger company ($63.06B vs $33.36B market cap).
•ZTS trades at the lower earnings multiple (13.20 vs 14.92 P/E).
•REGN converts more revenue to profit (29.65% vs 27.79% net margin).
•REGN grew revenue faster over the past five years (10.16% vs 6.28% CAGR).
•ZTS pays the higher dividend yield (2.59% vs 0.59%).

Which is better, REGN or ZTS?

Metric tally: REGN 6 · ZTS 10

It depends on what you're optimizing for:

ValueZTS(lower P/E)

GrowthREGN(faster 5Y revenue CAGR)

IncomeZTS(higher dividend yield)

QualityZTS(higher ROIC)

Valuation

Metric	REGN	ZTS
P/E ratio	14.92	13.20●
Forward P/E	11.30	10.75●
P/S ratio	4.42	3.53●
P/B ratio	2.10●	10.40
PEG ratio	3.38	2.04●
EV / EBITDA	11.43	10.15●
FCF yield	6.30%	6.35%

Profitability

Metric	REGN	ZTS
Gross margin	84.55%●	70.75%
Operating margin	24.32%	37.57%●
Net margin	29.65%●	27.79%
ROE	14.08%	81.75%●
ROIC	8.51%	21.54%●

Dividends

Metric	REGN	ZTS
Dividend yield	0.59%	2.59%●
Payout ratio	8.45%	34.16%

Growth (annualized)

Metric	REGN	ZTS
Revenue CAGR (5Y)	10.16%●	6.28%
EPS CAGR (5Y)	5.70%	11.88%●
FCF CAGR (5Y)	15.42%●	4.90%
Total return CAGR (5Y)	3.26%●	-14.40%

Frequently asked

Which is better, REGN or ZTS?: It depends on your goal. value: ZTS (lower P/E); growth: REGN (faster 5Y revenue CAGR); income: ZTS (higher dividend yield); quality: ZTS (higher ROIC). Across all compared metrics, ZTS leads 10 to 6.
Is REGN or ZTS cheaper?: On trailing earnings, ZTS is cheaper: REGN trades at a 14.92 P/E and ZTS at 13.20.
Which has grown faster, REGN or ZTS?: Over the past five years, REGN grew revenue faster — REGN at a 10.16% CAGR versus ZTS at 6.28%.
Does REGN or ZTS pay a bigger dividend?: REGN yields 0.59% and ZTS yields 2.59% based on trailing dividends and the latest price.
Is REGN or ZTS more profitable?: REGN runs the higher net margin — REGN at 29.65% versus ZTS at 27.79%.
Which has been the better investment, REGN or ZTS?: Over the past 10-year, ZTS delivered the higher annualized total return — REGN at 5.19% versus ZTS at 6.19%. Past performance doesn't predict future results.

Go deeper

Full REGN analysis Full ZTS analysis Interactive comparison tool

Dig into the metrics

Regeneron Pharmaceuticals P/E ratio Zoetis P/E ratio Regeneron Pharmaceuticals dividend yield Zoetis dividend yield Regeneron Pharmaceuticals ROE Zoetis ROE Regeneron Pharmaceuticals operating margin Zoetis operating margin Regeneron Pharmaceuticals revenue growth Zoetis revenue growth Regeneron Pharmaceuticals free cash flow Zoetis free cash flow

Regeneron Pharmaceuticals & Zoetis appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.